World News
-
MSD acquires Cidara Therapeutics for USD9.2B to strengthen influenza prevention pipeline
The pharmaceutical giant will pay USD221.50 per share in cash to purchase the US biotech company, which has developed an innovative platform called drug-Fc conjugates (DFCs).
-
GE HealthCare acquires Intelerad for USD2.3B to expand cloud-based imaging solutions
The acquisition aims to connect ambulatory care centers, teleradiology services, and hospital systems through unified imaging technology.
-
Moderna axes three clinical-stage mRNA candidates to focus R&D on oncology
A company spokesperson explained that Moderna has “prioritized our pipeline and R&D investments as part of our broader cost efficiency efforts,” though the company provided no additional details about the specific discontinuations.
-
Merck KGaA enters USD3B AI drug discovery partnership with Valo Health to target Parkinson’s disease
Through this partnership, Merck gains access to Valo’s advanced AI-powered human causal biology and discovery platforms, which the drugmaker will use to identify new disease targets and develop preclinical compounds.
-
Gavi leverages IFFIm to secure lower price for Malaria vaccine, accelerating protection goal
The deal promises to generate up to USD90 million in savings for Gavi and participating countries over the next five years.
-
Syntegon reports 19% sales growth in Q3 2025 driven by pharma innovation
The company’s Pharma business unit led the strong performance, delivering sales growth of 32%, including 20% organic growth.
-
AstraZeneca commits USD2B to expand Maryland manufacturing operations
The new facility will produce molecules for medical trials. These expansions will create 200 additional jobs in Frederick and 100 more in Gaithersburg.